Announcements Trials

Browse Landscape

Phase

Status

Unknown 27 Recruiting 12 Not yet recruiting 6 Active not recruiting 5 Withdrawn 1 Terminated 1 Enrolling by invitation 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Cisplatin 9 Specimen Handling 7 Educational Status 7 Standard of Care 6 Interviews as Topic 6 Drug Therapy 6 Carboplatin 6 Blood Specimen Collection 6 Radiotherapy 5 Nivolumab 5 Chemoradiotherapy 5 Surgical Procedures, Operative 4 Paclitaxel 4 Oxaliplatin 4 Observation 4 Lenalidomide 4 Fluorouracil 4 Dexamethasone 4 pembrolizumab 3 lenvatinib 3 camrelizumab 3 Surveys and Questionnaires 3 Practice Guidelines as Topic 3 Patient Navigation 3 Methods 3 Magnetic Resonance Spectroscopy 3 Magnetic Resonance Imaging 3 Gemcitabine 3 Fluorodeoxyglucose F18 3 Exercise 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Enrolling by invitation × aumolertinib × Clear all

NCT04762459 2022-02-24

APEX

ChineseAMS

Phase 3 Enrolling by invitation

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡